Search Knowledge Base

67 results for "embolism"

Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation pubmed_article
Evidence Source 2013 PMID: 23925867
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation pubmed_article
Evidence Source 2018 PMID: 29509959
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism pubmed_article
Evidence Source 2000 PMID: 10908494
Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism pubmed_article
Evidence Source 2006 PMID: 16437461
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis pubmed_article
Evidence Source 2014 PMID: 24996916
Dual-energy CT performance in acute pulmonary embolism: a meta-analysis pubmed_article
Evidence Source 2021 PMID: 33555356
Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 36814196
Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous thromboembolism: A meta-analysis pubmed_article
Evidence Source 2023 PMID: 37682131
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair pubmed_article
Evidence Source 2025 PMID: 39868562
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2000 PMID: 11034739
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2002 PMID: 11869618
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism pubmed_article
Evidence Source 2006 PMID: 16437432
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2008 PMID: 18425959
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement pubmed_article
Evidence Source 2010 PMID: 20393944
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2011 PMID: 21678361
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy pubmed_article
Evidence Source 2012 PMID: 22336844
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism pubmed_article
Evidence Source 2012 PMID: 23076894
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis pubmed_article
Evidence Source 2014 PMID: 24330006
Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity pubmed_article
Evidence Source 2013 PMID: 24343728
Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation pubmed_article
Evidence Source 2014 PMID: 24677203
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer pubmed_article
Evidence Source 2014 PMID: 25004410
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism cochrane_review
Evidence Source 2014 PMID: 25092359
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy pubmed_article
Evidence Source 2014 PMID: 25171736
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis pubmed_article
Evidence Source 2015 PMID: 26037103
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery pubmed_article
Evidence Source 2015 PMID: 26091835
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature pubmed_article
Evidence Source 2015 PMID: 26408921
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism pubmed_article
Evidence Source 2015 PMID: 26636644
Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis pubmed_article
Evidence Source 2015 PMID: 26716830
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair pubmed_article
Evidence Source 2016 PMID: 27027384
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy pubmed_article
Evidence Source 2016 PMID: 27906452

Evidence Search Results semantic · quality-ranked

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy meta_analysis pubmed_article
Quality: 74 2016 PMID: 27906452 DOI: 10.1002/14651858.CD008500.pub4
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism meta_analysis pubmed_article
Quality: 73 2023 PMID: 37057837 DOI: 10.1002/14651858.CD010957.pub3
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy meta_analysis pubmed_article
Quality: 73 2020 PMID: 33337539 DOI: 10.1002/14651858.CD008500.pub5
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer meta_analysis pubmed_article
Quality: 74 2018 PMID: 29920657 DOI: 10.1002/14651858.CD006650.pub5
Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation meta_analysis pubmed_article
Quality: 69 2024 PMID: 39278067 DOI: 10.1016/j.ctrv.2024.102827
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms meta_analysis pubmed_article
Quality: 66 2021 PMID: 33570633 DOI: 10.1182/bloodadvances.2020003628
Dual-energy CT performance in acute pulmonary embolism: a meta-analysis meta_analysis pubmed_article
Quality: 62 2021 PMID: 33555356 DOI: 10.1007/s00330-020-07633-8
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy meta_analysis pubmed_article
Quality: 75 2012 PMID: 22336844 DOI: 10.1002/14651858.CD008500.pub2
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism meta_analysis pubmed_article
Quality: 73 2015 PMID: 26636644 DOI: 10.1002/14651858.CD010957.pub2
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia systematic_review pubmed_article
Quality: 63 2020 PMID: 33038027 DOI: 10.1002/14651858.CD013399.pub2

View full evidence search →